More than 3 billion people worldwide suffer from oral diseases that create substantial medical burdens and compromise quality of life. Current treatments rely heavily on surgical interventions with material implantation, but bacterial colonization and excessive inflammatory responses often lead to poor healing outcomes and inadequate functional recovery.
Silicate biomaterials are emerging as a versatile solution with tunable physicochemical properties and demonstrated biosafety profiles. While these materials have been used in dentistry for decades primarily as bone grafts and sealants, recent research has unveiled broader therapeutic capabilities including antibacterial activity, immune system modulation, and promotion of nerve and blood vessel regeneration. Modern delivery approaches have evolved beyond traditional applications to include injectable hydrogels, microneedles, membrane patches, and 3D-printed scaffolds that enable minimally invasive, customized treatments.
This development represents a significant shift in oral medicine strategy. Rather than simply replacing damaged tissue, silicate biomaterials can actively participate in the healing process by controlling infection, reducing harmful inflammation, and promoting comprehensive tissue regeneration. The multi-functional approach addresses the complex pathophysiology of oral diseases more effectively than conventional single-purpose materials.
The practical implications are substantial for millions suffering from periodontal disease, tooth loss, and oral infections. However, translating these laboratory findings into clinical practice requires careful validation of long-term safety profiles and treatment protocols. While promising, most research remains in early development phases, and the transition from experimental applications to routine clinical use will require extensive clinical trials to establish optimal formulations and delivery methods for specific oral conditions.